Participation in another clinical trial of an investigational medicinal product <br/ > Known hypersensitivity to the IMP <br/ >Significant electrolyte disturbance (Hyperkalemia: K+ >5.0 mmol/L) <br/ >Patient currently receiving potassium sparing diuretics that cannot be reasonably <br/ >withheld <br/ >â?¢ Acute renal insufficiency <br/ >â?¢ In the Investigatorâ??s opinion, patient is unwilling or unable to comply with drug <br/ >administration plan, laboratory tests or other study procedures. <br/ >â?¢ Pregnant or lactating patient <br/ >â?¢ Patients on the following drugs : ACE inhibitors, Amiloride, Hydrocortisone, <br/ >Prednisolone, Methylprednisolone, Triamterene

Participation in another clinical trial of an investigational medicinal product <br/ > Known hypersensitivity to the IMP <br/ >Significant electrolyte disturbance (Hyperkalemia: K+ >5.0 mmol/L) <br/ >Patient currently receiving potassium sparing diuretics that cannot be reasonably <br/ >withheld <br/ >â?¢ Acute renal insufficiency <br/ >â?¢ In the Investigatorâ??s opinion, patient is unwilling or unable to comply with drug <br/ >administration plan, laboratory tests or other study procedures. <br/ >â?¢ Pregnant or lactating patient <br/ >â?¢ Patients on the following drugs : ACE inhibitors, Amiloride, Hydrocortisone, <br/ >Prednisolone, Methylprednisolone, Triamterene

N/A

N/A

Participation in another clinical trial of an investigational medicinal product <br/ > Known hypersensitivity to the IMP <br/ >Significant electrolyte disturbance (Hyperkalemia: K+ >5.0 mmol/L) <br/ >Patient currently receiving potassium sparing diuretics that cannot be reasonably <br/ >withheld <br/ >â?¢ Acute renal insufficiency <br/ >â?¢ In the Investigatorâ??s opinion, patient is unwilling or unable to comply with drug <br/ >administration plan, laboratory tests or other study procedures. <br/ >â?¢ Pregnant or lactating patient <br/ >â?¢ Patients on the following drugs : ACE inhibitors, Amiloride, Hydrocortisone, <br/ >Prednisolone, Methylprednisolone, Triamterene

Participation in another clinical trial of an investigational medicinal product <br/ > Known hypersensitivity to the IMP <br/ >Significant electrolyte disturbance (Hyperkalemia: K+ >5.0 mmol/L) <br/ >Patient currently receiving potassium sparing diuretics that cannot be reasonably <br/ >withheld <br/ >â?¢ Acute renal insufficiency <br/ >â?¢ In the Investigatorâ??s opinion, patient is unwilling or unable to comply with drug <br/ >administration plan, laboratory tests or other study procedures. <br/ >â?¢ Pregnant or lactating patient <br/ >â?¢ Patients on the following drugs : ACE inhibitors, Amiloride, Hydrocortisone, <br/ >Prednisolone, Methylprednisolone, Triamterene